GO:0001968 fibronectin binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001968 (fibronectin binding) is a molecular function describing the selective binding to fibronectin, a high-molecular-weight adhesive glycoprotein found on cell surfaces, in connective tissue matrices, and in extracellular fluids.
• Fibronectin binding is mediated by distinct protein domains, including the N-terminal domain, gelatin-binding domain, and cell-binding domain containing the RGD motif, which are recognized by integrins and other receptors [1,6].
• Bacterial pathogens such as Staphylococcus aureus, Borrelia burgdorferi, and Treponema denticola express fibronectin-binding proteins that promote adhesion, invasion, and immune evasion [2,3,4].
• Fibronectin binding regulates matrix assembly, collagen processing, and latent TGF-β activation, influencing tissue remodeling and fibrosis [5,7].
• Macrophage-derived fibronectin can suppress antitumor immunity via tissue stiffening and induction of immunosuppressive cells in cancer models.
• CRISPR-based knockout, knock-in, and overexpression models are essential to dissect the causal roles of fibronectin-binding proteins in health and disease.
Description
Fibronectin binding (GO:0001968) is a molecular function defined as the selective interaction with fibronectin, a large adhesive glycoprotein of the extracellular matrix (ECM) that is present on cell surfaces, in connective tissue matrices, and in body fluids. Fibronectin is a dimeric glycoprotein composed of modular domains that mediate binding to integrins, collagen, heparin, and other ECM components, thereby serving as a central organizer of matrix architecture and cell signaling [1,6]. The ability to bind fibronectin is a property of numerous cell-surface receptors, including integrins, and of many bacterial adhesins that exploit fibronectin for host colonization [2,3,4]. This function is critical for processes such as cell adhesion, migration, wound healing, and tissue homeostasis, and its dysregulation contributes to fibrosis, cancer progression, and infectious diseases [5,7,8]. Researchers study fibronectin binding to understand how cells and pathogens interact with the ECM, and to develop targeted therapies for conditions ranging from chronic wounds to metastatic cancer.
fibronectin binding At A Glance
| GO ID | GO:0001968 |
|---|---|
| GO term | fibronectin binding |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Binding to fibronectin, an adhesive glycoprotein of the extracellular matrix |
| Definition source | QuickGO |
| Related cellular component | Extracellular matrix, cell surface, extracellular fluid |
| Representative proteins | Integrins, bacterial fibronectin-binding proteins (e.g., FnBPA, FnBPB), fibronectin-binding protein TDE1579 |
| Associated processes | Cell adhesion, matrix assembly, collagen processing, TGF-β activation, pathogen invasion |
What Is GO:0001968?
According to the Gene Ontology, GO:0001968 (fibronectin binding) is the molecular function of binding to a fibronectin, a group of related adhesive glycoproteins of high molecular weight found on the surface of animal cells, connective tissue matrices, and in extracellular fluids. This term encompasses any protein or macromolecule that selectively interacts with fibronectin, whether through integrin receptors, bacterial adhesins, or other fibronectin-binding proteins. The function is defined by the physical interaction with fibronectin and does not imply a specific downstream outcome, although such binding often initiates signaling, matrix assembly, or pathogen attachment.
Why Is fibronectin binding Important in Cell Biology?
Fibronectin binding is a fundamental molecular function that bridges cells and pathogens to the extracellular matrix, influencing a wide range of physiological and pathological processes. It is essential for embryonic development, wound healing, and tissue repair, where fibronectin serves as a scaffold for cell migration and matrix assembly [1,5]. In infectious diseases, bacterial fibronectin-binding proteins are critical virulence factors that mediate adhesion to host tissues and invasion of host cells, as seen in Staphylococcus aureus, Borrelia burgdorferi, and Treponema denticola [2,3,4]. In cancer, fibronectin binding by integrins and other receptors promotes tumor cell survival, migration, and metastasis, and recent evidence shows that macrophage-derived fibronectin can suppress antitumor immunity through tissue stiffening. Furthermore, fibronectin binding regulates the activation of latent TGF-β, a key driver of fibrosis, making it a therapeutic target for fibrotic diseases. Understanding the molecular details of fibronectin binding is therefore crucial for developing interventions in infection, cancer, and fibrosis.
• Mediates cell adhesion and migration by linking cells to the extracellular matrix through integrins.
• Facilitates bacterial colonization and invasion, contributing to pathogenesis of S. aureus, Borrelia, and Treponema [2,3,4].
• Regulates extracellular matrix assembly and collagen processing by serving as a scaffold for procollagen proteinases.
• Controls activation of latent TGF-β, a central mediator of fibrosis and tissue remodeling.
• Promotes cancer progression by enhancing tumor cell survival, invasion, and immunosuppression.
• Involved in wound healing and tissue repair through provisional matrix formation.
• Target for anti-adhesion therapies in bacterial infections.
• Potential biomarker and therapeutic target in fibrotic diseases and cancer [7,8].
• Essential for embryonic development and organogenesis.
• Modulated by mechanical forces and matrix stiffness, influencing cell behavior.
What Happens During fibronectin binding?
Recognition and Initial Binding
In simple terms: Proteins on the cell surface or on bacteria recognize and attach to specific parts of fibronectin.
Fibronectin binding begins with the recognition of specific domains within the fibronectin molecule. Fibronectin is a dimer composed of modular repeats, including the N-terminal domain, gelatin-binding domain, and the cell-binding domain containing the RGD (Arg-Gly-Asp) motif [1,6]. Integrins, such as α5β1, bind to the RGD motif, while bacterial fibronectin-binding proteins (FnBPs) often recognize the N-terminal domain or other regions. This initial recognition is highly specific and is mediated by complementary structural motifs on the binding partner. For example, Staphylococcus aureus FnBPA and FnBPB bind to the N-terminal domain of fibronectin with high affinity. Similarly, Borrelia burgdorferi expresses fibronectin-binding activity that facilitates adhesion to host tissues.
Conformational Changes and Matrix Assembly
In simple terms: After binding, fibronectin molecules change shape and assemble into a network that supports cell growth and movement.
Upon binding to cell surface receptors, fibronectin undergoes conformational changes that expose cryptic self-assembly sites, leading to fibrillogenesis and matrix assembly [1,6]. This process is driven by integrin-mediated tension and requires the actin cytoskeleton. The assembled fibronectin matrix serves as a scaffold for other ECM proteins, including collagens and latent TGF-β-binding protein-1 (LTBP-1) [5,7]. The ED-A domain of fibronectin enhances the recruitment of LTBP-1 to the fibroblast matrix, which is critical for TGF-β activation. Dynamic structural studies of plasma fibronectin have revealed that it circulates in a compact, inactive conformation and unfolds upon binding to cells or surfaces, exposing domains for assembly.
Downstream Signaling and Cellular Responses
In simple terms: Binding to fibronectin triggers signals inside the cell that control growth, movement, and survival.
Fibronectin binding to integrins activates intracellular signaling pathways, including focal adhesion kinase (FAK), Src, and Rho GTPases, which regulate cell proliferation, migration, and survival. In bacterial infections, fibronectin binding can induce host cell signaling that promotes bacterial uptake, as shown for Treponema denticola TDE1579, which affects cytotoxicity. In cancer, fibronectin binding by integrins on tumor cells and macrophages activates immunosuppressive programs; macrophage-derived fibronectin suppresses antitumor immunity via tissue stiffening and induction of immunosuppressive cells. These signaling events are context-dependent and can be modulated by the mechanical properties of the matrix.
Regulation and Turnover
In simple terms: The amount and activity of fibronectin-binding proteins are controlled by the cell and can be altered in disease.
Fibronectin binding is regulated at multiple levels, including expression of fibronectin and its receptors, post-translational modifications, and proteolytic processing. Fibronectin matrix assembly is dynamically regulated by the balance of assembly and degradation, with proteases such as matrix metalloproteinases (MMPs) cleaving fibronectin and releasing fragments that can modulate cell behavior [1,5]. In bacterial pathogens, expression of fibronectin-binding proteins is often controlled by environmental signals and virulence regulators. In cancer, tumor-associated macrophages produce fibronectin that contributes to a stiffened ECM and immune suppression, suggesting that targeting fibronectin binding could enhance antitumor immunity.
Key Genes Involved in GO:0001968 fibronectin binding
The following genes encode proteins that directly bind fibronectin or regulate fibronectin-binding activity, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FN1 | Encodes fibronectin, the ligand for fibronectin-binding proteins | Central to ECM assembly, cell adhesion, and wound healing |
| ITGA5 | Integrin alpha-5 subunit, forms α5β1 fibronectin receptor | Mediates cell adhesion and signaling |
| ITGB1 | Integrin beta-1 subunit, partners with alpha-5 to bind fibronectin | Key for matrix assembly and mechanotransduction |
| FnBPA (S. aureus) | Fibronectin-binding protein A, bacterial adhesin | Virulence factor for host colonization |
| FnBPB (S. aureus) | Fibronectin-binding protein B, bacterial adhesin | Promotes invasion and immune evasion |
| BBK32 (Borrelia burgdorferi) | Fibronectin-binding protein | Mediates adhesion to host tissues |
| TDE1579 (Treponema denticola) | Fibronectin-binding protein | Affects cytotoxicity of Treponema denticola |
| LTBP1 | Latent TGF-β-binding protein 1, recruited to fibronectin matrix | Regulates TGF-β activation and fibrosis |
| COL1A1 | Type I collagen, interacts with fibronectin during matrix assembly | Collagen processing and tissue remodeling |
| COL1A2 | Type I collagen alpha-2 chain | Matrix assembly and fibrosis |
| MMP2 | Matrix metalloproteinase-2, degrades fibronectin | ECM turnover and cancer invasion |
| MMP9 | Matrix metalloproteinase-9, degrades fibronectin | Inflammation and tissue remodeling |
| TGFB1 | Transforming growth factor-beta 1, activated by fibronectin-mediated mechanisms | Fibrosis and immunosuppression |
| ITGAV | Integrin alpha-V, can bind fibronectin with beta subunits | Cell adhesion and signaling |
| ITGB3 | Integrin beta-3, forms αVβ3 fibronectin receptor | Angiogenesis and cancer |
| FAK (PTK2) | Focal adhesion kinase, downstream of fibronectin-integrin binding | Cell migration and survival |
| SRC | Proto-oncogene tyrosine-protein kinase Src, downstream signaling | Integrin signaling and cancer |
| RHOA | Rho GTPase, regulates cytoskeletal dynamics upon fibronectin binding | Cell contractility and matrix assembly |
How Is fibronectin binding Regulated?
Fibronectin binding is regulated at multiple levels. The expression of fibronectin and its receptors (integrins) is controlled by growth factors, cytokines, and mechanical cues [1,6]. For example, TGF-β1 induces fibronectin expression and enhances matrix assembly, creating a positive feedback loop that promotes fibrosis. The assembly of fibronectin into fibrils is regulated by integrin activation and cytoskeletal tension, and can be reversed by proteases such as MMPs [1,5]. In bacterial pathogens, the expression of fibronectin-binding proteins is often regulated by virulence regulators in response to environmental signals, such as in Staphylococcus aureus. Additionally, post-translational modifications of fibronectin, such as glycosylation and phosphorylation, can modulate its binding properties. In cancer, macrophage-derived fibronectin is regulated by tumor microenvironment signals, and its deposition contributes to tissue stiffening and immune suppression.
fibronectin binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FnBPA/FnBPB (S. aureus) | Bacterial infection and invasion | Knockout of FnBPs in S. aureus; infection of human cell lines |
| BBK32 (Borrelia burgdorferi) | Lyme disease | Knockout in B. burgdorferi; mouse infection model |
| TDE1579 (Treponema denticola) | Periodontal disease | Knockout in T. denticola; oral epithelial cell infection |
| FN1 | Fibrosis and cancer | Conditional knockout in fibroblasts; tumor models |
| LTBP1 | Fibrosis (TGF-β activation) | Knockout in fibroblasts; bleomycin-induced fibrosis model |
Fibronectin Binding in Bacterial Infections
Many bacterial pathogens exploit fibronectin binding to adhere to host tissues and initiate infection. Staphylococcus aureus expresses multifunctional fibronectin-binding proteins (FnBPA and FnBPB) that mediate adhesion to host cells, invasion, and immune evasion, making them key virulence factors. Borrelia burgdorferi, the causative agent of Lyme disease, exhibits fibronectin-binding activity that facilitates colonization of host tissues. Treponema denticola, a periodontal pathogen, expresses the fibronectin-binding protein TDE1579, which affects its cytotoxicity and may contribute to periodontal disease. These interactions are potential targets for anti-adhesion therapies.
Fibronectin Binding in Fibrosis and Tissue Remodeling
Fibronectin binding plays a central role in fibrosis by promoting matrix assembly and activation of latent TGF-β. The fibronectin ED-A domain enhances the recruitment of latent TGF-β-binding protein-1 (LTBP-1) to the fibroblast matrix, facilitating TGF-β activation, a master driver of fibrosis. Fibronectin also serves as a scaffold for procollagen proteinase binding and collagen processing, contributing to excessive collagen deposition in fibrotic tissues. Targeting fibronectin binding or its downstream effectors is a promising strategy for antifibrotic therapies.
Fibronectin Binding in Cancer
In cancer, fibronectin binding promotes tumor progression and immune evasion. Macrophage-derived fibronectin suppresses antitumor immunity via tissue stiffening and induction of immunosuppressive cells in mouse cancer models. Integrin-mediated fibronectin binding on tumor cells activates survival and migratory signaling pathways, enhancing metastasis. The fibronectin-rich tumor microenvironment also contributes to drug resistance. Therefore, interfering with fibronectin binding may improve cancer immunotherapy and reduce metastasis.
From fibronectin binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate fibronectin-binding protein affect cell adhesion? | CRISPR knockout in human cell lines (e.g., HeLa, HEK293) |
| Does a point mutation in the fibronectin-binding domain alter ligand interaction? | CRISPR point mutation knock-in in endogenous gene |
| Can a tagged fibronectin-binding protein be used for localization studies? | Knock-in of fluorescent or affinity tag (e.g., GFP, HA) |
| Does overexpression of a bacterial fibronectin-binding protein increase host cell invasion? | Overexpression in non-invasive bacteria or mammalian cells |
| What is the role of fibronectin binding in tumor immune evasion? | Knockout of FN1 in macrophages; syngeneic mouse tumor models |
| How does fibronectin binding regulate TGF-β activation? | Knockout of LTBP1 or ED-A domain of fibronectin in fibroblasts |
How to Study the fibronectin binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ELISA | Binding affinity between fibronectin and candidate proteins | Screening bacterial adhesins or integrins |
| Surface plasmon resonance (SPR) | Kinetics and affinity of fibronectin binding | Characterizing fibronectin-binding proteins |
| Cell adhesion assay | Attachment of cells to fibronectin-coated surfaces | Evaluating integrin function |
| Immunofluorescence | Localization of fibronectin and binding partners in matrix | Matrix assembly studies |
| Mass spectrometry | Identification of fibronectin-associated proteins | Discovery of novel binding partners |
| CRISPR knockout | Loss-of-function of candidate genes | Testing causal roles in fibronectin binding |
| Live-cell imaging | Dynamics of fibronectin fibrillogenesis | Real-time matrix assembly |
| Bioinformatics domain analysis | Prediction of fibronectin-binding domains | Genome-wide screening of adhesins |
Biochemical Binding Assays
Direct binding of proteins to fibronectin can be measured using enzyme-linked immunosorbent assay (ELISA), surface plasmon resonance (SPR), or isothermal titration calorimetry (ITC). These methods quantify affinity and kinetics of interactions between fibronectin and its binding partners, such as integrins or bacterial adhesins [2,3]. For example, the fibronectin-binding activity of Borrelia burgdorferi was characterized using binding assays.
Cell Adhesion and Migration Assays
Cell adhesion to fibronectin-coated surfaces and migration through fibronectin matrices are standard functional assays. These assays can be used to evaluate the impact of genetic perturbations (e.g., knockout of integrins or fibronectin-binding proteins) on cell behavior. Wound healing scratch assays and transwell migration assays are commonly employed.
Imaging and Matrix Assembly Studies
Fluorescence microscopy and live-cell imaging can visualize fibronectin matrix assembly and the recruitment of binding partners. Tagged fibronectin or fluorescently labeled fibronectin can be used to track fibrillogenesis. The recruitment of LTBP-1 to the fibronectin matrix can be assessed by immunofluorescence.
Proteomics and Bioinformatics
Mass spectrometry-based proteomics can identify proteins that co-precipitate with fibronectin, revealing novel binding partners. Bioinformatics analysis of protein domains (e.g., RGD motif, fibronectin-binding domains) can predict fibronectin-binding potential. These approaches are supported by structural studies of fibronectin.
How CRISPR Can Be Used to Study GO:0001968 fibronectin binding
Knockout
CRISPR knockout is used to eliminate the expression of genes encoding fibronectin-binding proteins or their receptors, enabling loss-of-function studies. For example, knocking out FN1 in macrophages can test its role in suppressing antitumor immunity. Knockout of bacterial fibronectin-binding proteins (e.g., FnBPA) can reduce host cell adhesion and invasion. In human cells, knockout of ITGA5 or ITGB1 abolishes fibronectin binding and downstream signaling.
Point Mutation
CRISPR point mutation knock-in allows precise modification of specific residues within fibronectin-binding domains to dissect their functional importance. For instance, mutating the RGD motif in fibronectin or the ligand-binding site in integrins can abolish binding without affecting protein expression. This approach is valuable for studying structure-function relationships.
Knock-in
Knock-in of tags (e.g., GFP, HA) or reporter genes into endogenous loci enables visualization and tracking of fibronectin-binding proteins in live cells. Tagged fibronectin can be used to monitor matrix assembly dynamics. Knock-in of disease-associated mutations can model human disorders related to fibronectin binding.
Overexpression
Overexpression of fibronectin-binding proteins or their receptors can enhance binding and downstream effects, useful for gain-of-function studies. For example, overexpressing FnBPA in non-invasive bacteria can confer invasiveness. In mammalian cells, overexpression of integrins can increase adhesion and migration. Overexpression models help identify sufficiency of a gene in driving phenotypes.
How EDITGENE Supports fibronectin binding Research
Researchers studying fibronectin binding-related genes often need to determine whether a candidate gene is causally involved in a specific biological process, such as bacterial invasion, matrix assembly, or immune suppression. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of fibronectin-binding proteins and their regulators.
Contact EDITGENE today to design your custom CRISPR model for fibronectin binding research.
Frequently Asked Questions About fibronectin binding
What is fibronectin binding (GO:0001968)?
Fibronectin binding is a molecular function defined by the Gene Ontology as the selective interaction with fibronectin, a high-molecular-weight adhesive glycoprotein found on cell surfaces, in connective tissue matrices, and in extracellular fluids.
What genes are involved in fibronectin binding?
Key genes include FN1 (encoding fibronectin), integrin subunits ITGA5 and ITGB1, bacterial adhesins such as FnBPA and FnBPB in Staphylococcus aureus, BBK32 in Borrelia burgdorferi, and TDE1579 in Treponema denticola [1,2,3,4].
How does fibronectin binding affect cell behavior?
Fibronectin binding mediates cell adhesion, migration, proliferation, and survival through integrin signaling, and regulates matrix assembly and TGF-β activation [1,7].
What diseases are associated with fibronectin binding?
Fibronectin binding is implicated in bacterial infections (e.g., S. aureus, Lyme disease, periodontal disease), fibrosis, and cancer progression and immune evasion [2,3,4,7,8].
How can I study fibronectin binding in the lab?
Common methods include ELISA, surface plasmon resonance, cell adhesion assays, immunofluorescence, and CRISPR-based genetic perturbation [1,2,3,6].
What is the role of fibronectin binding in cancer?
Macrophage-derived fibronectin suppresses antitumor immunity via tissue stiffening and induction of immunosuppressive cells, and integrin-mediated fibronectin binding promotes tumor cell survival and metastasis.
Which bacterial proteins bind fibronectin?
Staphylococcus aureus FnBPA and FnBPB, Borrelia burgdorferi BBK32, and Treponema denticola TDE1579 are well-characterized fibronectin-binding proteins [2,3,4].
How is fibronectin binding regulated?
It is regulated by expression levels of fibronectin and integrins, mechanical forces, proteolytic cleavage, and cytokines such as TGF-β [1,6,7].
What CRISPR models are available for fibronectin binding research?
EDITGENE offers knockout, point mutation knock-in, tagged knock-in, overexpression, and CRISPR library screening services for genes involved in fibronectin binding.
Why is fibronectin binding important for drug discovery?
It is a target for anti-adhesion therapies against bacterial infections, antifibrotic strategies, and cancer immunotherapy [2,7,8].
Conclusion
Fibronectin binding (GO:0001968) is a versatile molecular function that underpins critical interactions between cells, pathogens, and the extracellular matrix. Its roles in bacterial pathogenesis, tissue remodeling, fibrosis, and cancer immunity make it a compelling target for therapeutic intervention. Advances in CRISPR-based genome editing and functional genomics are accelerating the dissection of fibronectin-binding mechanisms and the identification of novel regulators. EDITGENE's comprehensive services empower researchers to generate precise cell models and uncover causal relationships, driving innovation in this important field.
References
- 1. Zollinger AJ et al.. 2017. Fibronectin, the extracellular glue.. Matrix Biol 60-61:27-37 PMID: 27496349
- 2. Foster TJ. 2016. The remarkably multifunctional fibronectin binding proteins of Staphylococcus aureus.. Eur J Clin Microbiol Infect Dis 35(12):1923-1931 PMID: 27604831
- 3. Grab DJ et al.. 1998. Fibronectin-binding activity in Borrelia burgdorferi1.. Biochim Biophys Acta 1407(2):135-45 PMID: 9685613
- 4. Xu X et al.. 2015. Fibronectin-binding protein TDE1579 affects cytotoxicity of Treponema denticola.. Anaerobe 36:39-48 PMID: 26456217
- 5. Saunders JT et al.. 2019. Fibronectin matrix as a scaffold for procollagen proteinase binding and collagen processing.. Mol Biol Cell 30(17):2218-2226 PMID: 31242089
- 6. Maurer LM et al.. 2015. Dynamic structure of plasma fibronectin.. Crit Rev Biochem Mol Biol 51(4):213-27 PMID: 27185500
- 7. Klingberg F et al.. 2018. The fibronectin ED-A domain enhances recruitment of latent TGF-β-binding protein-1 to the fibroblast matrix.. J Cell Sci 131(5) PMID: 29361522
- 8. Li A et al.. 2026. Macrophage-derived fibronectin suppresses antitumor immunity via tissue stiffening and immunosuppressive cell induction in cancer mouse models.. Nat Commun 17(1) PMID: 42173863
